Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIV colorectal cancer

Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIV colorectal cancer - FUTURE1203(SWIM IV)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009326

Enrollment

Registered

2012-11-14

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

StageIV patients with curative resection for colorectal cancer

Interventions

Within 8 weeks after Oxaliplatin based chemotherapy (UFT/LV Switch maintenance:5 course) UFT/LV p.o:4weeks on 1week off to be repeated every 5weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with curative resection for stageIV colorectal cancer 2.Patients recieved Oxaliplatin based chemotherapy 3.Possible patients using UFT/LV maintenance therapy 4.Age:20years to 80years 5.Performance Status:0-1 6.Patients sighed informed consent 7.Vital organ functions are preserved wiyhin 14days prior to entry

Exclusion criteria

Exclusion criteria: 1.Prior severe drug allergy 2.Nursing or pregnant females, or females or mailes with partners who are planning pregnancy 3.Presence of active infection 4.Serious complications 5.Inadequate cases for study enrollment by the physician

Design outcomes

Primary

Measure	Time frame
The complete of treatment,Safety	—

Secondary

Measure	Time frame
3year overall survival rate	—

Countries

Japan

Contacts

Public ContactYoichiro Yoshida

Fukuoka University Faculty of Medicine Department of Gastroenterological Surgery

yyoshida@fukuoka-u.ac.jp+928011011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026